Skip to main content
Equibles

SYMBIOX · Symbiox Investment & Trading C · Financials

Use SYMBIOX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SYMBIOX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1.60 INR +0.00 (+0.00%) At close · Nov 12
Rebalance outlook locked
Market Cap
50.06M INR
Shares
31.29M
Volume · Nov 12 19.54K Avg daily vol (3M) 13.23K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
16.03M -42%
FY2026 Revenue FY2025–FY2026
Net Income
1.51M -21.6%
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
27.26M -23.7%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025
INR 15.89M 16.03M 27.64M
INR 91K 29K 29K
INR 0 0 0
INR 1.92M 2.06M 2.59M
INR 516K 553K 674K
INR 1.41M 1.51M 1.92M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.